Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Rhythm Pharmaceuticals

Obesity Weekly News

Obesity Today—March 31, 2026

This week’s Obesity update highlights regulatory progress, advancing late-stage…

Obesity Weekly News

Obesity Today—March 24, 2026

This week’s Obesity update highlights regulatory progress, advancing clinical…

Obesity Weekly News

Obesity Video Recap—March 3, 2026

This biweekly Obesity video recap highlights late-stage combination data,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Respiratory Today—April 17, 2026
Vaccines Today—April 17, 2026
Public Health Today—April 17, 2026
Lucid Diligence Brief: Vir Biotechnology $1.37B collaboration with Astellas
Cardiovascular Today—April 16, 2026

Tags

Allergic Dermatitis Chronic disease mortality conduction-system pacing cost reduction DeRUCCI Diffuse Intrinsic Pontine Glioma DIPS Arena DTX301 Duchenne Muscular Dystrophy Cardiomyopathy Emboliner Enzalutamide ESSENCE FDA Digital Health Advisory FG001 Fitbit Personal Health Coach GLP-1 Receptor Agonists Gossamer Bio gout flares Hangzhou Sciwind Biosciences Heart Failure With Reduced Ejection Fraction HHS Jaypirca kyron.bio Lawrence Livermore National Laboratory live biotherapeutic product Mezigdomide MicroRNAs naxtarubicin OCALIVA Oryzon Genomics PepMetics Phthalates PPMS Pulmonary Hypertension Associated With Interstitial Lung Disease Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical TG Therapeutics Tilrekimig Transgene Ver-A-T1D X-Linked Protoporphyria YOLT-202

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Respiratory Today—April 17, 2026
Vaccines Today—April 17, 2026
Public Health Today—April 17, 2026
Lucid Diligence Brief: Vir Biotechnology $1.37B collaboration with Astellas
Cardiovascular Today—April 16, 2026

TAGS

Allergic Dermatitis Chronic disease mortality conduction-system pacing cost reduction DeRUCCI Diffuse Intrinsic Pontine Glioma DIPS Arena DTX301 Duchenne Muscular Dystrophy Cardiomyopathy Emboliner Enzalutamide ESSENCE FDA Digital Health Advisory FG001 Fitbit Personal Health Coach GLP-1 Receptor Agonists Gossamer Bio gout flares Hangzhou Sciwind Biosciences Heart Failure With Reduced Ejection Fraction HHS Jaypirca kyron.bio Lawrence Livermore National Laboratory live biotherapeutic product Mezigdomide MicroRNAs naxtarubicin OCALIVA Oryzon Genomics PepMetics Phthalates PPMS Pulmonary Hypertension Associated With Interstitial Lung Disease Rinvoq Rituximab Spikevax Stanford Medicine Sutra Medical TG Therapeutics Tilrekimig Transgene Ver-A-T1D X-Linked Protoporphyria YOLT-202

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy